Literature DB >> 10980109

Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin's disease.

F M Raaphorst1, F J van Kemenade, T Blokzijl, E Fieret, K M Hamer, D P Satijn, A P Otte, C J Meijer.   

Abstract

The human BMI-1 and EZH2 polycomb group (PcG) proteins are constituents of two distinct complexes of PcG proteins with gene regulatory activity. PcG proteins ensure correct embryonic development by suppressing homeobox genes, and they also contribute to regulation of lymphopoiesis. The two PcG complexes are thought to regulate different target genes and probably have different tissue distributions. Altered expression of PcG genes is linked to transformation in cell lines and induction of tumors in mutant mice, but the role of PcG genes in human cancers is relatively unexplored. Using antisera specific for human PcG proteins, we used immunohistochemistry and immunofluorescence to detect BMI-1 and EZH2 PcG proteins in Reed-Sternberg cells of Hodgkin's disease (HRS). The expression patterns were compared to those in follicular lymphocytes of the lymph node, the normal counterparts of HRS cells. In the germinal center, expression of BMI-1 is restricted to resting Mib-1/Ki-67(-) centrocytes, whereas EZH2 expression is associated with dividing Mib-1/Ki-67(+) centroblasts. By contrast, HRS cells coexpress BMI-1, EZH2, and Mib-1/Ki-67. Because HRS cells are thought to originate from germinal center lymphocytes, these observations suggests that Hodgkin's disease is associated with coexpression of BMI-1 and EZH2 in HRS cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10980109      PMCID: PMC1885707          DOI: 10.1016/S0002-9440(10)64583-X

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  48 in total

Review 1.  Identifying the precursors of Hodgkin and Reed-Sternberg cells in Hodgkin's disease: role of the germinal center in B-cell lymphomagenesis.

Authors:  R Küppers
Journal:  J Acquir Immune Defic Syndr       Date:  1999-08-01       Impact factor: 3.731

2.  Somatic mutations within the untranslated regions of rearranged Ig genes in a case of classical Hodgkin's disease as a potential cause for the absence of Ig in the lymphoma cells.

Authors:  A Jox; T Zander; R Küppers; J Irsch; H Kanzler; M Kornacker; H Bohlen; V Diehl; J Wolf
Journal:  Blood       Date:  1999-06-01       Impact factor: 22.113

3.  Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin.

Authors:  H D Foss; R Reusch; G Demel; G Lenz; I Anagnostopoulos; M Hummel; H Stein
Journal:  Blood       Date:  1999-11-01       Impact factor: 22.113

4.  Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF.

Authors:  J J Jacobs; B Scheijen; J W Voncken; K Kieboom; A Berns; M van Lohuizen
Journal:  Genes Dev       Date:  1999-10-15       Impact factor: 11.361

5.  Reed-Sternberg cell genome expression supports a B-cell lineage.

Authors:  J Cossman; C M Annunziata; S Barash; L Staudt; P Dillon; W W He; P Ricciardi-Castagnoli; C A Rosen; K C Carter
Journal:  Blood       Date:  1999-07-15       Impact factor: 22.113

6.  Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells.

Authors:  U Schwab; H Stein; J Gerdes; H Lemke; H Kirchner; M Schaadt; V Diehl
Journal:  Nature       Date:  1982-09-02       Impact factor: 49.962

7.  Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants.

Authors:  S Beà; M Ribas; J M Hernández; F Bosch; M Pinyol; L Hernández; J L García; T Flores; M González; A López-Guillermo; M A Piris; A Cardesa; E Montserrat; R Miró; E Campo
Journal:  Blood       Date:  1999-06-15       Impact factor: 22.113

8.  Cutting edge: polycomb gene expression patterns reflect distinct B cell differentiation stages in human germinal centers.

Authors:  F M Raaphorst; F J van Kemenade; E Fieret; K M Hamer; D P Satijn; A P Otte; C J Meijer
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

9.  RING1 interacts with multiple Polycomb-group proteins and displays tumorigenic activity.

Authors:  D P Satijn; A P Otte
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

10.  The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus.

Authors:  J J Jacobs; K Kieboom; S Marino; R A DePinho; M van Lohuizen
Journal:  Nature       Date:  1999-01-14       Impact factor: 49.962

View more
  44 in total

1.  Site-specific expression of polycomb-group genes encoding the HPC-HPH/PRC1 complex in clinically defined primary nodal and cutaneous large B-cell lymphomas.

Authors:  Frank M Raaphorst; Maarten Vermeer; Elly Fieret; Tjasso Blokzijl; Danny Dukers; Richard G A B Sewalt; Arie P Otte; Rein Willemze; Chris J L M Meijer
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

2.  Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation.

Authors:  Damian B Yap; Justin Chu; Tobias Berg; Matthieu Schapira; S-W Grace Cheng; Annie Moradian; Ryan D Morin; Andrew J Mungall; Barbara Meissner; Merrill Boyle; Victor E Marquez; Marco A Marra; Randy D Gascoyne; R Keith Humphries; Cheryl H Arrowsmith; Gregg B Morin; Samuel A J R Aparicio
Journal:  Blood       Date:  2010-12-29       Impact factor: 22.113

Review 3.  The Polycomb group protein Enhancer of Zeste 2: its links to DNA repair and breast cancer.

Authors:  Michael Zeidler; Celina G Kleer
Journal:  J Mol Histol       Date:  2006-07-20       Impact factor: 2.611

4.  The Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion.

Authors:  Leonie M Kamminga; Leonid V Bystrykh; Aletta de Boer; Sita Houwer; José Douma; Ellen Weersing; Bert Dontje; Gerald de Haan
Journal:  Blood       Date:  2005-11-17       Impact factor: 22.113

5.  Dual inhibition of EZH1/2 breaks the quiescence of leukemia stem cells in acute myeloid leukemia.

Authors:  S Fujita; D Honma; N Adachi; K Araki; E Takamatsu; T Katsumoto; K Yamagata; K Akashi; K Aoyama; A Iwama; I Kitabayashi
Journal:  Leukemia       Date:  2017-09-27       Impact factor: 11.528

6.  Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis.

Authors:  Roderick H J Breuer; Peter J F Snijders; Egbert F Smit; Thomas G Sutedja; Richard G A B Sewalt; Arie P Otte; Folkert J van Kemenade; Pieter E Postmus; Chris J L M Meijer; Frank M Raaphorst
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

7.  EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis.

Authors:  Cheng-Gang Wang; Ying-Jiang Ye; Jing Yuan; Fang-Fang Liu; Hui Zhang; Shan Wang
Journal:  World J Gastroenterol       Date:  2010-05-21       Impact factor: 5.742

Review 8.  The biology of Hodgkin's lymphoma.

Authors:  Ralf Küppers
Journal:  Nat Rev Cancer       Date:  2008-12-11       Impact factor: 60.716

9.  The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival.

Authors:  Sivaprakasam Balasubramanian; Gautam Adhikary; Richard L Eckert
Journal:  Carcinogenesis       Date:  2009-12-16       Impact factor: 4.944

10.  Expression and clinicopathological significance of Mel-18 and Bmi-1 mRNA in gastric carcinoma.

Authors:  You-Wei Lu; Jin Li; Wei-Jian Guo
Journal:  J Exp Clin Cancer Res       Date:  2010-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.